The cellular mechanisms of Leber's hereditary optic neuropathy (LHON) are poorly understood and there is little information on the onset of blindness and neurological degeneration. Here we define the relationship between oxidative stress and LHON pathogenicity at the cellular level. Venous blood was obtained from 14 patients with LHON, 21 asymptomatic maternal relatives and 30 normal individuals (controls). The level of free radicals in blood was assessed as luminol luminescence immediately and at 10 min after addition of phytohaemagglutinin. In LHON patients and their asymptomatic relatives, free radicals increased significantly immediately after adding phytohaemagglutinin compared with baseline and normal controls. After 10 min, however, there were no significant differences between and within the groups. These results suggest that the antioxidant capacity is reduced in the blood of patients with LHON and in asymptomatic relatives, and that oxidative stress plays a significant role in the pathogenesis of LHON.
Introduction
Leber's hereditary optic neuropathy (LHON) is a maternally transmitted disease that is characterized by acute or subacute bilateral loss of central vision in young adults. It has been associated with 27 different mitochondrial DNA (mtDNA) mutations, which have been classified as primary and secondary mutations according to their aetiological role in disease expression. 1 Although the primary cause of LHON is a mutation in the mitochondrial genome, the presence of a primary mtDNA mutation does not necessarily lead to vision loss. 2 Recent research has shown that the occurrence of LHON is associated with oxidative stress. 3, 4 The present study measured total free radicals in blood from LHON patients and asymptomatic maternal relatives. Antioxidant capacity is altered by the presence of mitochondrial DNA11778 point mutations, 5 measured by clinical testing of blood from patients with LHON and asymptomatic individuals. We used phytohaemagglutinin (PHA) to induce oxidative stress in blood samples and a chemical luminescence technique to examine the blood samples after oxidative stress. The purpose was to establish whether oxidative stress is involved in the pathogenesis of LHON and to derive a theoretical basis for further research into finding effective prevention of LHON in high-risk individuals. 
CHEMILUMINESCENCE METHODS
Venous blood samples (3 ml) from each tested individual were maintained at 4°C with citrate sodium anticoagulation, and were tested on the same or the following day.
Blood (1 ml) was extracted from the sample and placed in a colourless polypropylene tube, then mixed with 0.8 ml phosphate buffered saline (10 mM, pH 7.2 -7.4) and incubated for 20 min in a warm bath (37°C). Ten minutes after adding luminol (Sigma, St Louis, MO, USA) to the samples, 1 ml of 0.4 mg/ml phytohaemagglutinin (Sigma) was added and the relative luminescence was measured immediately and again after 10 min with a tube luminescence detector and the T2 program (Lumat LB 9507; Berthold Technologies, Bad Wilbad, Germany).
STATISTICAL ANALYSES
All statistical analyses were performed using SPSS ® for Windows ® version 11.0 (SPSS Inc., Chicago, IL, USA). Data are presented as JY Wang, YS Gu, J Wang et al. Oxidative stress in Chinese patients with Leber's hereditary optic neuropathy mean ± SD. Between-group comparisons were performed using the two-tailed Student's t-test. A P-value < 0.05 was considered statistically significant.
Results

CLINICAL CHARACTERISTICS
A total of 14 patients with LHON, 21 asymptomatic maternal relatives and 30 control subjects were enrolled into the study and were used for screening for the presence of mtDNA mutations.
The age of onset of visual loss ranged from 9 to 23 years but was typically between the ages of 10 and 18 years. The course of visual loss was generally acute or subacute, but in some patients it was slowly progressive ( Table 1 ). Both eyes were involved, with or without an interval between onset in the two eyes; the mean interval between onset in the two eyes was 1.8 months. The mean duration of progression of visual loss in each eye was 4 months. Initially, the optic discs were hyperaemic and the nerve fibre layer was swollen ( Fig. 1A ). There was circumpapillary telangiectatic microangiopathy and swelling of the nerve fibre layer around the disc without leakage of fluorescein dye. Microangiopathy occurred in some asymptomatic family members over several years. These fundus changes were absent or minimal in some cases, even at the acute stage of visual loss. Over subsequent months, the disc oedema faded, leaving a picture of diffuse optic atrophy that was more severe on the temporal side, with or without cupping ( Fig. 1B) . A caecocentral scotoma was the usual defect detected on visual field examination, and a variable degree of peripheral vision was preserved.
MITOCHONDRIAL DNA11778 MUTATION SEQUENCING
A mitochondrial DNA 11778 G to A mutation was seen in leucocytes from LHON patients and their asymptomatic maternal Fig. 2A ). All control subjects were negative for this mutation (Fig. 2B ).
CHEMILUMINESCENCE CHANGE
The level of free radicals in blood samples from LHON patients and their asymptomatic relatives increased immediately after adding PHA and was significantly different (P < 0.05) from that in the normal control subjects at this time point. However, there was no statistically significant difference between LHON patients and their asymptomatic relatives immediately after adding PHA, and there were no significant differences among all groups 10 min after adding PHA (Table 2 ).
Discussion
LHON is a mitochondrial genetic disease that preferentially causes blindness in young adult males, affecting about 1 in 25 000 of the British population. 6 It is characterized by bilateral subacute loss of central vision owing to focal degeneration of the retinal ganglion cell layer and optic nerve. More than 95% of cases of LHON are primarily the result of one of three mitochondrial DNA point mutations -G3460A, G11778A and T14484C -all of 1, 7 A metaanalysis from northern Europe and Australia showed that G11778A was the most prevalent LHON mutation. 6, 8 The predominance of G11778A is even more marked in Chinese people with LHON, in whom it accounts for about 90% of all LHON cases. 9 Although pathogenic mitochondrial DNA mutations are necessary for the triggering of LHON, other factors are also believed to be required and most of these are not well defined. LHON is the most familiar clinical mitochondrial disease, and the effects of oxidative stress and reactive oxygen species on the progression of the disease are of great interest to researchers at present. 10, 11 In eucaryotic cells, mitochondria are the site of energy production and ATP (adenosine triphosphate) synthesis by oxidative phosphorylation. The oxidative phosphorylation system consists of multiple carriers and molecules that are collectively referred to as the electron transport chain. Oxidation of fuel molecules produces NADH (nicotinamide adenine dinucleotide, reduced) and FADH 2 (flavin adenine dinucleotide, reduced), and electrons generated from NADH/FADH 2 are transferred between complexes I -IV and molecular oxygen, the final electron acceptor. The transfer of electrons releases energy that is stored in the form of a proton gradient across the mitochondrial membrane, and this energy is used to produce ATP. Individual cells contain many mitochondria and each mitochondrion has hundreds to thousands of DNA molecules. Mitochondrial DNA is a circular, intronless molecule that has a higher mutation rate than nuclear DNA because the mtDNA molecule is not protected by histones, is exposed to reactive oxygen species generated during oxidative phosphorylation and is replicated in the absence of a proofreading function. Deletions or mutations in mitochondrial DNA underlie several complex human disorders, the pathophysiology of which includes alterations in mitochondrial bioenergetics. In patients with mitochondrial DNA-associated syndromes, complex I deficiency is the most common disorder and, of the several documented mitochondrial DNA complex I mutations, most are associated with LHON or LHON-associated syndromes. 12 Our group has performed comparative research among LHON patients and their asymptomatic maternal relatives, focusing on oxidative and antioxidant indexes in serum, such as nitric oxide, nitric oxide synthase, vitamin E, glutathione, superoxide dismutase, Data with the same letter are significantly different from each other (P < 0.05).
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glutathione-S-transferase and malonyl dialdehyde. We found metabolic disturbances of the free radical system in the serum of both LHON patients and their asymptomatic maternal relatives. We believe that measuring and observing single targets is insufficient to indicate the level of antioxidants in the body, because many substances are able to participate in antioxidant functions, such as albumin, urate, ascorbic acid and bilirubin, and even some substances that cannot be measured. 13 Furthermore, oxygen free radicals are active chemicals with short halflives of decay and, although they can be measured by direct methods, such as the pulse radiolysis technique for fast kinetic chasing in the nanosecond range or linking freezing with the electron paramagnetic resonance spectroscopy technique, indirect methods are generally adopted. These include cytochrome c reduction, nitroblue tetrazolium reduction and adrenaline reduction, and they indirectly measure oxygen free radical content by chromatometry analysis of the chemical changes that they produce. Direct methods mostly require expensive apparatus; moreover, they are difficult to carry out in the laboratory. Indirect methods involve complex operational procedures and are of low sensitivity.
The present study was able to overcome these disadvantages by using the chemical luminescence technique to measure oxygen free radicals. The results revealed that the whole blood of patients with LHON and their normal, asymptomatic relatives contained free radicals whose generation was rapidly stimulated by PHA and these were present in amounts greater than those in normal control subjects. The results also showed that antioxidant ability in LHON patients and their asymptomatic maternal relatives was relatively weak. Thus, in the presence of external stimulation by oxidative stress, it is relatively easy to disrupt the balance between pro-oxidant and antioxidant activity in tissues or cells in LHON, indicating that oxidative stress plays a significant role in the pathogenesis of LHON. A respiratory burst could create diverse oxygen free radicals, and this is likely to result in a series of positive feedback reactions leading to the apoptosis of retinal ganglion cells; these are sensitive in terms of energy metabolism and are active in producing free radicals. 14 The latter has been confirmed by investigation of the histological structure and functions of the pre-and postoptic nerve sieve plate and the papillomacular bundle. 15, 16 We found no significant difference in relative luminescence among the groups after 10 min, indicating that the body responded to the oxidative stress. When a large number of free radicals are produced during a respiratory burst, the body is still able to exert some metabolic control and regulation, but eventually LHON may develop as a result of the interactions of a number of factors, including reactive oxygen species, mitochondrial DNA mutations, the nuclear DNA background, autoimmunity and the environment.
Although more details about the pathophysiology of LHON are needed, particularly with regard to optic neuropathy and oxidative stress, the decreased antioxidant capacity of the blood of LHON patients and their asymptomatic maternal relatives suggests that it is reasonable for current therapy during the acute period of LHON to comprise single agents (for example polyphenol drugs) or multiple drug cocktails, including antioxidants.
